Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
2(40.0%)
5Total
N/A(3)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05929937Phase 4Active Not Recruiting

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair

Role: lead

NCT05599750Not ApplicableRecruiting

Suture Repair vs Mesh Repair for Incisional Hernia

Role: lead

NCT05985343Phase 4Completed

The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction

Role: lead

NCT04007952Not ApplicableCompleted

Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair

Role: lead

NCT03972553Not ApplicableCompleted

Parastomal Hernia Repair Utilizing the Retromuscular Sugarbaker Versus Keyhole Mesh Techniques

Role: lead

All 5 trials loaded